Founded Year

2017

Stage

Series A | Alive

Total Raised

$16.7M

Last Raised

$12M | 1 yr ago

About Outcomes4Me

Outcomes4Me builds an integrated platform that provides patients and their families with new ways to engage with healthcare systems globally.

Outcomes4Me Headquarter Location

210 Broadway Suite 201

Cambridge, Massachusetts, 02139,

United States

617-812-1010

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Outcomes4Me's Products & Differentiation

See Outcomes4Me's products and how their products differentiate from alternatives and competitors

  • Clinical trial recruitment

    We refer patients to clinical trial recruitment site by bringing in Just-In-Time Qualified LeadsTM to accelerate clinical trial recruitment

    Differentiation

    We have direct patient and medical record access with a three level matching approach that leads to much lower screening failure then the competition 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Outcomes4Me

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Outcomes4Me is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Outcomes4Me Patents

Outcomes4Me has filed 1 patent.

The 3 most popular patent topics include:

  • Electronic health records
  • Health informatics
  • Health standards
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/11/2019

Health informatics, Electronic health records, Telehealth, Healthcare quality, Health standards

Application

Application Date

12/11/2019

Grant Date

Title

Related Topics

Health informatics, Electronic health records, Telehealth, Healthcare quality, Health standards

Status

Application

Latest Outcomes4Me News

Outcomes4Me Announces Results from a Breast Cancer Patient Study Conducted in Collaboration with Mass General Cancer Center at the San Antonio Breast Cancer Symposium 2021

Dec 9, 2021

Accuracy of Patient Self-Reported Disease Characteristics Compared to Medical Record Data Presents Important Discrepancies December 09, 2021 08:00 AM Eastern Standard Time BOSTON & SAN ANTONIO--( BUSINESS WIRE )-- Outcomes4Me Inc. , a developer of a leading free mobile app and platform to navigate cancer treatment and care, announced today, at the San Antonio Breast Cancer Symposium , findings from a study done in collaboration with the Mass General Cancer Center, Boston. The pilot study analyzed the concordance of patient reported disease characteristics compared to electronic medical record (EMR) data. Outcomes4Me found that the data clearly points to the need for patients to have a better understanding of their breast cancer diagnosis. Patients’ understanding of their breast cancer diagnosis is important in order to improve treatment adherence, shared decision-making, and clinical trial matching. The study shows important discrepancies between EMR and patient self-reported information, shining a light on the need for better patient education and medical records access. The study, which collected data via a survey and an in-app questionnaire between June 2020 to December 2020, found that 97 percent of the study cohort reported that they “somewhat” or “strongly” understood their cancer diagnosis. Yet, 24 percent of patients answered “I don’t know” or “I’m not sure” to fundamental questions about their disease characteristics including hormone receptor (HR) status, and/or HER2 status. “There is no doubt that the inaccuracies found in self-reporting suggest a need for improved patient education regarding key cancer characteristics and a need for caution when relying on self-reported characteristics for clinical trials matching and targeted patient education,” said Maya R. Said, Sc. D., founder and CEO of Outcomes4Me. “These findings underscore a problem that all stakeholders here at the SABCS – practicing providers and researchers – involved in breast cancer need to have top of mind. The burden of improving patients’ understanding of breast cancer should not be on the patient alone.” The study also found that HR and HER2 status had limited concordance with the EMR, in contrast to a high degree of accuracy in self-reported metastatic status. Receptor status is critically important to understanding breast cancer and what treatment options are available, including clinical trials. Yet, only 55 to 61 percent of patients accurately self-reported their HR and/or HER2 status. In particular, HER2 status was only reported accurately among 64 to 70 percent of the cohort, compared to 79 to 89 percent of patients accurately reporting their metastatic status. “Patient education is critical to shared decision making,” said Steven Isakoff, MD, PhD, Breast Oncologist at Mass General Cancer Center and lead author on the study. “Patients need to have a better understanding of their breast cancer diagnosis in order to have more informed decision-making conversations. Without accurately knowing critical disease characteristics, our patients are not in the best position to make informed decisions with their oncologist.” These results further highlight the need for digital platforms to integrate self-reported characteristics with EMR access to help provide accurate patient information to address these critical needs. The Outcomes4Me platform was developed to enable this integration with a goal to impact patient empowerment and care. The Outcomes4Me app is available free to users on both the App Store and Google Play. More about the Outcomes4Me Inc. study, done in collaboration with the Mass General Cancer Center, Boston: Data was analyzed from a single institution pilot study (NCT04262518) and eligibility included breast cancer patients with any subtype or stage of invasive cancer presenting with a new diagnosis or for follow-up on active therapy. Outcomes4Me compared patient reported characteristics within a study specific survey and/or the Outcomes4Me app for stage (metastatic or not metastatic), recurrence history, hormone receptor status, HER2, and surgery history with the data recorded in the EMR. All statistics were descriptive. The company conducted the same comparison between patient reported clinical characteristics among real world users of the Outcomes4Me app and EMR records downloaded by that cohort of patients. Access to the SABCS poster can be found on sabcs.org . About Outcomes4Me Outcomes4Me is on a mission to improve health outcomes by empowering patients with understandable, relevant and evidence-based information. Outcomes4Me has developed a platform for shared decision-making between patients and providers. The platform harnesses regulatory-grade, real-world data and patient experiences generating deeper insights and better outcomes to improve care and accelerate research. The Outcomes4Me mobile app enables cancer patients to make decisions and take control of their care based on information that is personalized to their specific condition, including finding treatment options, matching to clinical trials, and tracking and managing symptoms. Based in Boston, Massachusetts, Outcomes4Me, a woman-led company, comprises seasoned healthcare, oncology, pharmaceutical, consumer and technology veterans. For more information, visit www.outcomes4me.com . Contacts

Outcomes4Me Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Outcomes4Me Rank

  • When was Outcomes4Me founded?

    Outcomes4Me was founded in 2017.

  • Where is Outcomes4Me's headquarters?

    Outcomes4Me's headquarters is located at 210 Broadway, Cambridge.

  • What is Outcomes4Me's latest funding round?

    Outcomes4Me's latest funding round is Series A.

  • How much did Outcomes4Me raise?

    Outcomes4Me raised a total of $16.7M.

  • Who are the investors of Outcomes4Me?

    Investors of Outcomes4Me include Sierra Ventures, Asset Management Ventures, Merstal, IRA Capital and Northpond Ventures.

  • Who are Outcomes4Me's competitors?

    Competitors of Outcomes4Me include Jasper Health and 1 more.

  • What products does Outcomes4Me offer?

    Outcomes4Me's products include Clinical trial recruitment and 3 more.

  • Who are Outcomes4Me's customers?

    Customers of Outcomes4Me include Invitae and Foundation Medicine.

You May Also Like

TrialSpark Logo
TrialSpark

TrialSpark is a clinical trial management software and drug development company. The company aims to accelerate the pace of clinical trials and bring down costs with a software platform that helps sites like hospitals manage trials and collect and analyze data. Per the company, it uses data from social media to find doctors and patients to participate.While it began as a clinical trial technology platform, in 2021, it signaled a move to using its technology for drug development through the acquisition of biologic and small-molecule drugs. TrialSpark began primarily as a technology company that aims to bring treatments to patients faster using technology that improves clinical trials and drug development. TrialSpark has scaled a network of trial sites by partnering with doctors to create clinical trial sites within their existing practices. TrialSpark runs trials out of these doctor practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology. Without variability in operations at the trial site level, TrialSpark cuts out the manual, time-intensive, and costly tasks that delay clinical trial timelines. By creating trial sites with doctors, TrialSpark unlocks the 98 percent of patients who have never been exposed to trials, boosting recruitment and enrollment rates and democratizing access.

L
Lightship

Lightship offers direct-to-patient clinical trial solutions.

PatientsLikeMe Logo
PatientsLikeMe

PatientsLikeMe is an online health data sharing platform. PatientsLikeMe creates new knowledge by charting the real-world course of disease through the shared experiences of patients. While patients interact to help improve their outcomes, the data provided helps researchers learn how these diseases act in the real world and accelerate the discovery of new, more effective treatments.

Deep 6 AI Logo
Deep 6 AI

Deep 6 AI finds patients for clinical trials in minutes rather than months. Using artificial intelligence and natural language processing on clinical data, Deep 6 AI's software accelerates patient recruitment exponentially, getting life-saving treatment to patients more quickly.

Neucruit Logo
Neucruit

Neucruit is a patient recruitment platform for clinical trials that uses real-time data to help biopharmaceutical companies, site teams, and investigators enhance site selection and optimize patient recruitment materials.

Trialbee Logo
Trialbee

Trialbee is a dynamic software company with a single purpose of accelerating clinical research. The company provides software solutions that optimize the clinical trial process by enabling all stakeholders to easily communicate and collaborate on a joint platform.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.